During the past ten years much information has been accumulated concerning the interaction of tritiated estrogens with hormone-dependent tissues. Their striking affinity for estradiol, both in vivol-5 and in vitro,6-9 first suggested that such target tissues as uterus, vagina, and anterior pituitary possess unique components called "estrogen receptors." Strong but reversible association of hormone with receptor, without chemical transformation of the steroid molecule, appears to be a primary step in the uterotrophic process, not affected by such inhibitors of early estrogen response as puromycin or actinomycin D.10 The interaction of estradiol with target tissues involves two distinct phenomenauptake and retention; the latter process, but not the former, becomes saturated in vivo if the hormone administered exceeds the physiological level.1'
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Centrifugal fractionation experiments'0-'4 demonstrate two sites of estrogen binding in uterine cells. As confirmed by autoradiography,"5 16 most estradiol, both in endometrium and in myometrium, resides in the nuclei, but a certain amount is bound to a macromolecular substance appearing in the supernatant fraction. Toft and Gorski"7 made the important observation that the radioactive estradiol-receptor complex in the supernatant fraction can be characterized by ultracentrifugation in sucrose density gradients where it migrates with a sedimentation coefficient of 9.5S; disruption of the complex by proteases but not by nucleases suggests that the receptor substance is a protein. We have confirmed these findings and have observed further8-20 that a different estradiol-receptor complex, sedimenting at about 5S, can be extracted from uterine nuclei by cold 0.3 M KC1, which solubilizes little uterine DNA.21 Although the 9.5S complex does not appear to be a simple aggregate of the 5S, the two receptor substances show many similar characteristics, discussed in more detail elsewhere.22 An important difference is the ability of the 9.5S complex to form spontaneously on addition of tritiated estradiol to supernatant fraction;9' 20 23 the 5S complex is not produced by adding estradiol to nuclear extract,24 although it can be formed in the whole homogenate.
This paper presents evidence that the 9.5S receptor is extranuclear and involved in estrogen uptake, whereas the nuclear 5S complex, probably responsible for hormone retention and growth initiation, is formed from the 9.5S complex by a process which consumes 9.5S receptor and which is retarded at low temperature. The binding capacity of a supernatant fraction was determined by mixing a 200-IAl portion with 50 1Al of Tris-EDTA containing various amounts of tritiated estradiol; after standing 30 min at 20, a 200-Idu aliquot was analyzed on a sucrose gradient. In recombination experiments, the rinsed sediment from 26 pairs of uterine horns was resuspended by gentle homogenization in 3.3 ml cold Tris-EDTA buffer. Aliquot portions (0.8 ml) were mixed at 00 with solutions prepared-by adding 0.2 ml of 1.7 X 10-8 M estradiol-6, 7-H3 in Tris-EDTA to 0.8 ml of the three media described in Figure 3 . After incubation, the three suspensions were chilled, centrifuged, and the resulting sediments extracted with 0.3 1 KC1.
Results.-Ratio of supernatant to nuclear binding: When rat uteri, previously exposed to tritiated estradiol in vivo or at 370 in vitro, are homogenized in hypotonic Tris-EDTA, the supernatant fraction, which contains no significant radioactive component except 9.5S complex, represents 20 to 25 per cent of the uterine estradiol. If exposure to estradiol is carried out at 20 for a brief period, the proportion of the total radioactivity present as 9.5S complex is markedly increased (Table 1 ). After such uteri are removed from the hormone solution, much of the 9.5S estradiol undergoes transfer to the nucleus. This redistribution is slow at 2°(expt. 9b), but at 370 the level of 9.5S complex falls to "normal" within 15 VOL. 59, 1968 633 minutes (expt. S). AMore than half of the 9.5S radioactivity which disappears during warming can be extracted from the nuclei in the form of 'S complex.
Localization of the 9.5S receptor: The question whether the 9.5S receptor is extranuclear or whether it is extracted from the nucleus during homogenization cannot be answered definitively by autoradiography of uteri in which the 9.5S complex comprises a small fraction of the total radioactivity. Because the extranuclear space greatly exceeds the nuclear volume, the concentration of such an extranuclear component may be too low to permit detection in the presence of the concentrated nuclear radioactivity. Uterine tissue with a high content of 9.5S complex, more favorable for autoradiographic localization of the 9.58 receptor, can be obtained after estradiol uptake at 2°.
Autoradiographs of uteri exposed to estradiol at 37°in vitro show nuclear concentration of radioactivity (Fig. 1A) (Fig.  1B) . The correlation of this extranuclear radioactivity with specific cytoplasmic or membranal components must await the application of staining techniques which delineate extranuclear cell structure.
Binding capacity of the 9.5S receptor: Because of the spontaneous formation of the 9.5S estradiol-receptor complex, the total 9.5S binding capacity of a supernatant fraction can be measured by adding to it increasing amounts of tritiated estradiol until the radioactivity of the 9.5S peak on subsequent gradient cen- (Fig. 2) . Similar lack of saturation was observed two hours after injecting 0.05 or 0.2 Ag of hormone in vivo or after uptake of physiological or hyperphysiological amounts of estradiol in vitro.
In none of the foregoing experiments does the saturation value of the supernatant fraction represent the original level of 9.5S receptor in uterine tissue. This substance is rather labile and begins to disappear soon after the tissues are ex-VOL. 5) 9, 1968 635 cised; moreover, exposure of uteri to estradiol depletes their 9.5S receptor content, as discussed below. By working rapidly at low temperature with uteri not previously treated with hormone, the extradiol-binding capacity of the supernatant fraction was found to be about 100 femtomoles per mg wet uterine tissue or about 2.1 picomoles per pair of horns. This value, which represents a 9.5S binding capacity double that of Figure 2A and more than twice that reported by Toft et al., 23 undoubtedly is still lower than the actual level in the original tissue. Depletion of 9.5S binding capacity during estradiol uptake: In addition to the lack of saturation of the 9.5S factor, Figure 2 also reveals that there is a significant reduction in total supernatant binding capacity as the dose of estradiol is increased. The areas under the peaks at saturation indicate that the supernatant fraction of uteri excised 15 minutes after a 0.5-,ug dose of estradiol contains 13.8 femtomoles less binding capacity per mg wet tissue than it does after 0.05 ,Ig of hormone. Similar depletion of 9.5S binding capacity with increased estradiol dose was observed two hours after injection of hormone in vivo and in uteri exposed to various concentrations of estradiol in vitro. In three out of four experiments, the decrease in 9.5S binding capacity corresponded closely to the increased amount of 5S complex which could be extracted from the nuclei. It would appear that as more estradiol enters uterine nuclei to form 58 complex, the content of 9.5S receptor in the supernatant fraction is significantly lowered.
Requirement of a supernatant factor for 5S complex formation: Direct evidence for the participation of the supernatant fraction in the formation of the 5S estradiol-receptor complex is provided by experiments in which the particulate sediment from untreated uteri was incubated with: (A) supernatant fraction to which tritiated estradiol was added and shown to be present entirely as 9.5S complex; (B) estradiol in supernatant fraction which had been warmed to 450 for 30 minutes, destroying 9.5S binding; and (C) estradiol in Tris-EDTA buffer. During five minutes at 370 the sediments took up 66, 54, and 64 per cent, respectively, of the total radioactivity, about one third of which was solubilized in each case by a single extraction with 0.3 M KCl. Only in group A, in which the nuclei had been exposed to estradiol in the form of 9.5S complex, did the extract consist of 5S complex (Fig. 3) . Similar results were obtained when the incubation of nuclear sediment with the three different estradiol-containing media was carried out at 100 for 30 minutes. It would appear that although uterine nuclei can take up and bind free estradiol, formation of 5S estradiol-receptor complex requires the presence of unheated supernatant fraction containing estradiol in the form of 9.5S complex.
Discussion.
-The foregoing observations demonstrate that the uterine 9.5S factor participates both in estradiol uptake by uterine cells and in the formation of 5S estradiol-receptor complex in their nuclei. Autoradiographic studies of uteri, rich in radioactive 9.5S complex, show this factor to be extranuclear; the spontaneous formation of the 9.5S complex, even at 20, indicates low activation energy for the uptake process. The high uterine content of 9.5S factor, not saturated even at hyperphysiological estradiol levels, explains the nonsaturable capacity of uterine tissue for initial estradiol uptake in vivo."
Experiments with recombined homogenate fractions show that a heat-labile supernatant factor is required for production of 5S complex, suggesting that estradiol must be presented to the nucleus as 9.5S complex in order for 5S complex to be formed. In whole uterine horns, transfer of estradiol from a 9.5S to a 5S form takes place readily at 370 but slowly at 20, suggesting that this process requires activation energy and possibly may be enzymatic. As estradiol is taken up by the nucleus, either in vivo or in vitro, 9.5S binding capacity disappears, indicating that the 9.5S receptor either is destroyed as it delivers estradiol to the nucleus or else that it actually is transformed into 5S receptor by loss of a molecular fragment. Investigations to determine whether uterine nuclei contain an enzyme catalyzing the selective degradation of the 9.5S complex are presently underway.
Summary.-The interaction of estradiol with uterine tissue appears to involve a two-stage mechanism. The hormone associates spontaneously with an extranuclear "uptake" receptor to form a 9.5S complex, a phenomenon which utilizes only a small portion of the total amount of this receptor available. The 9.5S complex transfers estradiol to the nucleus by a temperature-dependent process which consumes 9.5S receptor. Formation of the characteristic 5S complex by the nucleus requires the presence of supernatant fraction containing estradiol in VOL. 59, 1968 
